256 related articles for article (PubMed ID: 26034172)
1. Bruton's Tyrosine Kinase Synergizes with Notch2 To Govern Marginal Zone B Cells in Nonobese Diabetic Mice.
Case JB; Bonami RH; Nyhoff LE; Steinberg HE; Sullivan AM; Kendall PL
J Immunol; 2015 Jul; 195(1):61-70. PubMed ID: 26034172
[TBL] [Abstract][Full Text] [Related]
2. Reduced diabetes in btk-deficient nonobese diabetic mice and restoration of diabetes with provision of an anti-insulin IgH chain transgene.
Kendall PL; Moore DJ; Hulbert C; Hoek KL; Khan WN; Thomas JW
J Immunol; 2009 Nov; 183(10):6403-12. PubMed ID: 19841184
[TBL] [Abstract][Full Text] [Related]
3. Intrinsic molecular factors cause aberrant expansion of the splenic marginal zone B cell population in nonobese diabetic mice.
Stolp J; Mariño E; Batten M; Sierro F; Cox SL; Grey ST; Silveira PA
J Immunol; 2013 Jul; 191(1):97-109. PubMed ID: 23740954
[TBL] [Abstract][Full Text] [Related]
4. Bruton's tyrosine kinase promotes persistence of mature anti-insulin B cells.
Bonami RH; Sullivan AM; Case JB; Steinberg HE; Hoek KL; Khan WN; Kendall PL
J Immunol; 2014 Feb; 192(4):1459-70. PubMed ID: 24453243
[TBL] [Abstract][Full Text] [Related]
5. Reduced dosage of Bruton's tyrosine kinase uncouples B cell hyperresponsiveness from autoimmunity in lyn-/- mice.
Whyburn LR; Halcomb KE; Contreras CM; Lowell CA; Witte ON; Satterthwaite AB
J Immunol; 2003 Aug; 171(4):1850-8. PubMed ID: 12902486
[TBL] [Abstract][Full Text] [Related]
6. Constitutive activation of Bruton's tyrosine kinase induces the formation of autoreactive IgM plasma cells.
Kersseboom R; Kil L; Flierman R; van der Zee M; Dingjan GM; Middendorp S; Maas A; Hendriks RW
Eur J Immunol; 2010 Sep; 40(9):2643-54. PubMed ID: 20623551
[TBL] [Abstract][Full Text] [Related]
7. Cellular maturation defects in Bruton's tyrosine kinase-deficient immature B cells are amplified by premature B cell receptor expression and reduced by receptor editing.
Middendorp S; Hendriks RW
J Immunol; 2004 Feb; 172(3):1371-9. PubMed ID: 14734712
[TBL] [Abstract][Full Text] [Related]
8. Analysis of marginal zone B cell development in the mouse with limited B cell diversity: role of the antigen receptor signals in the recruitment of B cells to the marginal zone.
Kanayama N; Cascalho M; Ohmori H
J Immunol; 2005 Feb; 174(3):1438-45. PubMed ID: 15661902
[TBL] [Abstract][Full Text] [Related]
9. Impaired precursor B cell differentiation in Bruton's tyrosine kinase-deficient mice.
Middendorp S; Dingjan GM; Hendriks RW
J Immunol; 2002 Mar; 168(6):2695-703. PubMed ID: 11884435
[TBL] [Abstract][Full Text] [Related]
10. Toll-Like Receptor Signaling Drives Btk-Mediated Autoimmune Disease.
Rip J; de Bruijn MJW; Appelman MK; Pal Singh S; Hendriks RW; Corneth OBJ
Front Immunol; 2019; 10():95. PubMed ID: 30761150
[TBL] [Abstract][Full Text] [Related]
11. Bruton's Tyrosine Kinase Is Not Essential for B Cell Survival beyond Early Developmental Stages.
Nyhoff LE; Clark ES; Barron BL; Bonami RH; Khan WN; Kendall PL
J Immunol; 2018 Apr; 200(7):2352-2361. PubMed ID: 29483358
[TBL] [Abstract][Full Text] [Related]
12. Bruton's tyrosine kinase and SLP-65 regulate pre-B cell differentiation and the induction of Ig light chain gene rearrangement.
Kersseboom R; Ta VB; Zijlstra AJ; Middendorp S; Jumaa H; van Loo PF; Hendriks RW
J Immunol; 2006 Apr; 176(8):4543-52. PubMed ID: 16585544
[TBL] [Abstract][Full Text] [Related]
13. Multiple germline kappa light chains generate anti-insulin B cells in nonobese diabetic mice.
Woodward EJ; Thomas JW
J Immunol; 2005 Jul; 175(2):1073-9. PubMed ID: 16002708
[TBL] [Abstract][Full Text] [Related]
14. The role of Bruton's tyrosine kinase in autoimmunity and implications for therapy.
Crofford LJ; Nyhoff LE; Sheehan JH; Kendall PL
Expert Rev Clin Immunol; 2016 Jul; 12(7):763-73. PubMed ID: 26864273
[TBL] [Abstract][Full Text] [Related]
15. BCR engagement induces Fas resistance in primary B cells in the absence of functional Bruton's tyrosine kinase.
Tumang JR; Negm RS; Solt LA; Schneider TJ; Colarusso TP; Hastings WD; Woodland RT; Rothstein TL
J Immunol; 2002 Mar; 168(6):2712-9. PubMed ID: 11884437
[TBL] [Abstract][Full Text] [Related]
16. Absence of mature peripheral B cell populations in mice with concomitant defects in B cell receptor and BAFF-R signaling.
Hoek KL; Carlesso G; Clark ES; Khan WN
J Immunol; 2009 Nov; 183(9):5630-43. PubMed ID: 19843948
[TBL] [Abstract][Full Text] [Related]
17. Notch2 haploinsufficiency results in diminished B1 B cells and a severe reduction in marginal zone B cells.
Witt CM; Won WJ; Hurez V; Klug CA
J Immunol; 2003 Sep; 171(6):2783-8. PubMed ID: 12960298
[TBL] [Abstract][Full Text] [Related]
18. Function of Bruton's tyrosine kinase during B cell development is partially independent of its catalytic activity.
Middendorp S; Dingjan GM; Maas A; Dahlenborg K; Hendriks RW
J Immunol; 2003 Dec; 171(11):5988-96. PubMed ID: 14634110
[TBL] [Abstract][Full Text] [Related]
19. CD19 regulates ADAM28-mediated Notch2 cleavage to control the differentiation of marginal zone precursors to MZ B cells.
Zhang Y; Zhu G; Xiao H; Liu X; Han G; Chen G; Hou C; Shen B; Li Y; Ma N; Wang R
J Cell Mol Med; 2017 Dec; 21(12):3658-3669. PubMed ID: 28707394
[TBL] [Abstract][Full Text] [Related]
20. Bruton's tyrosine kinase mediates NF-kappa B activation and B cell survival by B cell-activating factor receptor of the TNF-R family.
Shinners NP; Carlesso G; Castro I; Hoek KL; Corn RA; Woodland RT; Scott ML; Wang D; Khan WN
J Immunol; 2007 Sep; 179(6):3872-80. PubMed ID: 17785824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
